FI89909B - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sulfonamidderivat och mellanprodukter - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sulfonamidderivat och mellanprodukter Download PDF

Info

Publication number
FI89909B
FI89909B FI884070A FI884070A FI89909B FI 89909 B FI89909 B FI 89909B FI 884070 A FI884070 A FI 884070A FI 884070 A FI884070 A FI 884070A FI 89909 B FI89909 B FI 89909B
Authority
FI
Finland
Prior art keywords
formula
give
vacuo
evaporated
preparation
Prior art date
Application number
FI884070A
Other languages
English (en)
Finnish (fi)
Other versions
FI89909C (sv
FI884070A (fi
FI884070A0 (fi
Inventor
Peter Edward Cross
John Edmund Arrowsmith
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of FI884070A0 publication Critical patent/FI884070A0/fi
Publication of FI884070A publication Critical patent/FI884070A/fi
Publication of FI89909B publication Critical patent/FI89909B/fi
Application granted granted Critical
Publication of FI89909C publication Critical patent/FI89909C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (3)

1. Förfarande för framställning av nya terapeu-tiskt användbara sulfonamidderivat med formeln I och far- 5 maceutiskt godtagbara salter därav, Π ^^A^NCH2CH2Y>*JS0?R (I)
10 XJ - W H - RS0»N 7 i "H i vilken formel symbolerna R, som är lika, betecknar C1.4-15 alkyl, X är CH2 eller O och Y är O eller en direkt bind-ning, kännetecknat därav, att en förening med formeln H_,N C 25 där X och Y betecknar samma som ovan, omsätts med anting-en (a) en C1.4-alkansulfonylklorid eller -bromid eller (b) en C1.4-alkansulfonsyraanhydrid, varefter, om sä önskas, en erhällen förening med formeln I omvandlas tili ett 30 farmaceutiskt godtagbart sait.
2. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att en förening med formeln III omsätts med en C1.4-alkansulfonylklorid i närvaro av en sy-raacceptor. 35 1: 29 0 9 9 0 9
3. Förening raed formeln f-\ 5 f~ Z (II) z"^ där X är CH2 eller O, Y är O eller en direkt bindning och 10 symbolerna Z, som är lika, betecknar nitro eller amino.
FI884070A 1987-09-05 1988-09-02 Förfarande för framställning av nya terapeutiskt användbara sulfonamid derivat och mellanprodukter FI89909C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8720910 1987-09-05
GB878720910A GB8720910D0 (en) 1987-09-05 1987-09-05 Antiarrhythmic agents
CA000567186A CA1291164C (en) 1987-09-05 1988-05-19 Indane sulfonamide antiarrythmic agents
CA567186 1988-05-19

Publications (4)

Publication Number Publication Date
FI884070A0 FI884070A0 (fi) 1988-09-02
FI884070A FI884070A (fi) 1989-03-06
FI89909B true FI89909B (fi) 1993-08-31
FI89909C FI89909C (sv) 1993-12-10

Family

ID=25671902

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884070A FI89909C (sv) 1987-09-05 1988-09-02 Förfarande för framställning av nya terapeutiskt användbara sulfonamid derivat och mellanprodukter

Country Status (13)

Country Link
EP (1) EP0307121B1 (sv)
JP (1) JP2653850B2 (sv)
AT (1) ATE73773T1 (sv)
CA (2) CA1291164C (sv)
DD (1) DD281596A5 (sv)
DE (1) DE3869289D1 (sv)
DK (1) DK488588A (sv)
ES (1) ES2032972T3 (sv)
FI (1) FI89909C (sv)
GB (1) GB8720910D0 (sv)
GR (1) GR3004627T3 (sv)
IE (1) IE61505B1 (sv)
PT (1) PT88406B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
AU653837B2 (en) * 1991-04-17 1994-10-13 Pharmacia & Upjohn Company Substituted phenylazacycloalkanes as CNS agents
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
DE4335718A1 (de) * 1993-10-20 1995-04-27 Merck Patent Gmbh Cyclische Aminderivate
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
US7812035B2 (en) 2001-12-11 2010-10-12 Sepracor Inc. 4-substituted piperidines, and methods of use thereof
GB2543296A (en) * 2015-10-13 2017-04-19 Indivior Uk Ltd Dopamine D3 receptor antagonists having a morpholine moiety
CN118251382A (zh) * 2021-11-08 2024-06-25 豪夫迈·罗氏有限公司 芳硝基化合物的催化氢化

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
DE3476386D1 (de) * 1983-11-02 1989-03-02 Beecham Group Plc Morpholine derivatives
EP0164865B1 (en) * 1984-05-04 1988-12-21 The Upjohn Company N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use

Also Published As

Publication number Publication date
ES2032972T3 (es) 1993-03-01
JP2653850B2 (ja) 1997-09-17
FI89909C (sv) 1993-12-10
DD281596A5 (de) 1990-08-15
IE61505B1 (en) 1994-11-02
DE3869289D1 (de) 1992-04-23
FI884070A (fi) 1989-03-06
CA1291164C (en) 1991-10-22
GR3004627T3 (sv) 1993-04-28
GB8720910D0 (en) 1987-10-14
EP0307121B1 (en) 1992-03-18
PT88406B (pt) 1992-10-30
DK488588D0 (da) 1988-09-02
JPS6471856A (en) 1989-03-16
PT88406A (pt) 1989-07-31
CA1320726C (en) 1993-07-27
IE882665L (en) 1989-03-05
EP0307121A1 (en) 1989-03-15
ATE73773T1 (de) 1992-04-15
DK488588A (da) 1989-03-06
FI884070A0 (fi) 1988-09-02

Similar Documents

Publication Publication Date Title
FI89909B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sulfonamidderivat och mellanprodukter
CA1054602A (en) PYRROLIDINE AND PIPERIDINE CONTAINING (.omega.-PERFLUOROALKOXY) BENZAMIDES AND PROCESSES FOR THEIR PREPARATION
US4629739A (en) Substituted sulfonamidobenzamides and method of treating arrhythmias
EP0233051A2 (en) Antiarrhythmic Agents
US4673675A (en) 1-(2-pyridyl) 4-cycloalkylmethyl piperazines having cardiotropic activity
EP0424525B1 (en) Novel amines and their use
US5006561A (en) Indane sulfonamide anti-arrhythmic agents and use
DK163181B (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
DK170818B1 (da) Phenylpiperidin-derivater, farmaceutiske præparater indeholdende disse og deres anvendelse til fremstilling af lægemidler
EP0284384B1 (en) Anti-arrhythmic agents
PL172933B1 (pl) Sposób wytwarzania nowych pochodnych 3(2H)-pirydazononu PL
US4727072A (en) 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents
SU1344245A3 (ru) Способ получени N- (3- алкиламинопропил) -N @ - фенилмочевины или их фармакологически приемлемых солей /его варианты/
JPS62267250A (ja) 抗不整脈剤
US3984557A (en) Antiarrhythmia compositions and methods
US4005209A (en) Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides
DK160486B (da) N-(4-amino-2,2-diphenyl-butyl)- eller n-(3-amino-2,2-diphenyl-propyl) urinstofforbindelser, fremgangsmaade til fremstilling af disse, samt en farmaceutisk komposition
CS255884B2 (en) Process for preparing derivatives of substituted 3-phenyliminothiazolidine
US4758563A (en) 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use
US4013670A (en) Derivatives of pyrrolidine and piperidine
US3325500A (en) Mono- and bis-[(1-piperidyl)-loweralkyl]amines
US3105006A (en) Novel nu-arylsulfonyl-nu'-(1, 2, 3, 6-tetrahydro-1-pyridyl) ureas and oral antidiabetic compositions
US3576819A (en) Esters of alpha-(1-substituted-3-pyrrolidinyl)-alpha-phenyl acetic acid
US4922021A (en) New alkylene diamine derivatives
CS239947B2 (en) Processing of new benzazepin derivatives

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER LIMITED